Marshall Wace’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.45M Buy
26,687
+25,187
+1,679% +$3.62M ﹤0.01% 1498
2025
Q4
$214K Sell
1,500
-1,040
-41% -$139K ﹤0.01% 2572
2025
Q3
$305K Buy
+2,540
New +$322K ﹤0.01% 2424
2024
Q3
Sell
-5,647
Closed -$671K 2707
2024
Q2
$671K Sell
5,647
-54,007
-91% -$5.68M ﹤0.01% 1848
2024
Q1
$6.4M Sell
59,654
-2,294
-4% -$228K 0.01% 896
2023
Q4
$6.18M Buy
+61,948
New +$6.06M 0.01% 835
2023
Q2
Sell
-2,401
Closed -$396K 2673
2023
Q1
$396K Buy
+2,401
New +$413K ﹤0.01% 2194
2021
Q4
Sell
-2,056
Closed -$479K 4047
2021
Q3
$479K Buy
+2,056
New +$431K ﹤0.01% 2411
2021
Q2
Sell
-2,887
Closed -$593K 2833
2021
Q1
$593K Buy
+2,887
New +$610K ﹤0.01% 1878
2020
Q3
Sell
-16,671
Closed -$3.07M 1738
2020
Q2
$3.07M Buy
16,671
+16,373
+5,494% +$3.25M 0.02% 628
2020
Q1
$60K Buy
+298
New +$57.4K ﹤0.01% 1397
2019
Q3
Sell
-17,945
Closed -$4.52M 1787
2019
Q2
$4.52M Buy
17,945
+3,438
+24% +$797K 0.04% 521
2019
Q1
$3.47M Sell
14,507
-69,335
-83% -$16.6M 0.03% 575
2018
Q4
$19.3M Sell
83,842
-69,418
-45% -$17.1M 0.2% 119
2018
Q3
$43.3M Buy
+153,260
New +$44.9M 0.37% 60
2016
Q4
Sell
-20,120
Closed -$2.54M 1034
2016
Q3
$2.54M Sell
20,120
-115,336
-85% -$13.9M 0.02% 544
2016
Q2
$15.3M Buy
135,456
+22,019
+19% +$2.29M 0.13% 181
2016
Q1
$11.8M Sell
113,437
-1,117
-1% -$107K 0.11% 189
2015
Q4
$12.9M Buy
114,554
+64,003
+127% +$7.07M 0.12% 194
2015
Q3
$5.54M Buy
+50,551
New +$5.41M 0.07% 276
2014
Q2
Sell
-7,219
Closed -$432K 990
2014
Q1
$432K Buy
+7,219
New +$445K 0.01% 610

Other funds holding ICUI

Marshall Wace's ICUI Position: Q1 2026 in Review

Marshall Wace increased its ICU Medical (ICUI) stake by 1,679% in Q1 2026, buying an estimated $3.62M and bringing the position to 26,687 shares worth $3.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1498.

Marshall Wace first reported a position in ICUI in Q1 2014 and has held it in 21 quarters since. The position peaked at $43.3M in Q3 2018. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Marshall Wace held 26,687 shares of ICU Medical worth $3.45M as of Q1 2026.
  • Marshall Wace bought 25,187 ICU Medical shares in Q1 2026, an estimated $3.62M.
  • ICU Medical made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1498 holding.
  • Marshall Wace first reported a position in ICU Medical in Q1 2014 and has held it in 21 quarters since.
  • Marshall Wace's ICU Medical position peaked at $43.3M in Q3 2018.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.